Sometimes it's a clear supply chain
GLP-1 receptor agonists, like the active ingredient in Zepbound, improve the bodys sensitivity to insulin
Preventing the 'Skinny Fat' Phenomenon Losing weight on GLP-1 medications can sometimes result in a lower number on the scale but a persistently high body fat percentage, a condition often called being skinny fat. This happens when muscle mass is lost alongside fat, leaving the body leaner but still with excess fat relative to muscle
CrossRef Thrombosis and anticoagulation in patients with Cirrhosis
Common side effects include gastrointestinal symptoms (nausea, vomiting, diarrhoea)
The nasal spray format contributes to this movement by offering an elegant, repeatable, and efficient way to study how GLP-1 analogs behave in metabolic scenarios